Bisphosphonate-associated osteonecrosis: experiences in a private practice.
Marder
Michael Z
MZ
Columbia University College of Dental Medicine, New York, NY, USA. mzm2@columbia.edu
Marder
Robert W
RW
D000368:Aged; D000369:Aged, 80 and over; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D017606:Chlorine Compounds / Q000627:therapeutic use; D004164:Diphosphonates / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced* / Q000188:drug therapy; D008297:Male; D008339:Mandibular Neoplasms / Q000188:drug therapy / Q000556:secondary; D008875:Middle Aged; D009067:Mouthwashes / Q000627:therapeutic use; D010020:Osteonecrosis / Q000139:chemically induced* / Q000188:drug therapy; D010087:Oxides / Q000627:therapeutic use; D021362:Palate, Hard / Q000187:drug effects; D011331:Private Practice
D050071:Bone Density Conservation Agents; D017606:Chlorine Compounds; D004164:Diphosphonates; D009067:Mouthwashes; D010087:Oxides; C025109:chlorine dioxide